Checkmate Pharmaceuticals (CMPI) News Today → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free CMPI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCheckmate Pharmaceuticals, Inc. (NASDAQ:CMPI) Short Interest Updatemarketbeat.com - May 30 at 10:46 AMmarketbeat.com - May 30 at 6:02 AMUniversity of Iowa Holden Comprehensive Cancer Center Presentstmcnet.com - May 26 at 11:58 PMUniversity of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meetingfinance.yahoo.com - May 26 at 6:36 PM Analysts Expect Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) to Post -$0.75 Earnings Per Sharemarketbeat.com - May 20 at 8:22 AMINVESTIGATION NOTICE: Halper Sadeh LLP Investigates TVTY, ACC, SWCH, CMPIapnews.com - May 18 at 3:20 AMCheckmate Pharmaceuticals GAAP EPS of -$0.73 beats by $0.02seekingalpha.com - May 13 at 1:15 AMCheckmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 13 at 1:15 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NLSN, CMPI, SBOWapnews.com - May 5 at 11:49 PM-$0.73 EPS Expected for Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) This Quartermarketbeat.com - April 29 at 10:13 PMCheckmate Pharmaceuticals, Inc. (NASDAQ:CMPI) Major Shareholder Global Strategic Fund I. Venbio Sells 47,396 Sharesmarketbeat.com - April 29 at 7:13 PMRegeneron (REGN) to Buy Checkmate Pharmaceuticals for $250Mmsn.com - April 20 at 12:57 PMShareholder Alert: Ademi LLP investigates whether Checkmate Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Regeneronbarrons.com - April 20 at 1:55 AMCheckmate stock quadruples on news of Regenerate acquisitionbizjournals.com - April 19 at 3:52 PMWhy Checkmate Pharmaceuticals Stock Is Rocketing Higher Todayfinance.yahoo.com - April 19 at 3:52 PMCMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholdersstockhouse.com - April 19 at 9:47 AMCheckmate Pharmaceuticals Shares Take Flight on Regeneron Deal >CMPImarketwatch.com - April 19 at 9:47 AMmarketbeat.com - April 19 at 7:00 AMCheckmate Pharmaceuticals Presents Clinical Trial Biomarker Data withtmcnet.com - April 8 at 7:10 PMCheckmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - April 8 at 7:10 PMCheckmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meetingnz.finance.yahoo.com - March 8 at 7:46 PMCheckmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - March 8 at 7:46 PMThe Petri Dish: Syndax, Checkmate get new CEOs; Biogen stays in biosimilars gamebizjournals.com - February 10 at 6:34 AMCheckmate Pharmaceuticals appoints Alan Bash as President, CEOseekingalpha.com - February 9 at 10:32 AMCheckmate Pharmaceuticals Appoints Alan Bash as President and CEOfinance.yahoo.com - February 9 at 10:32 AMCheckmate Pharmaceuticals, Inc. Common Stock (CMPI)nasdaq.com - January 31 at 10:35 PMCheckmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directorsfinance.yahoo.com - January 31 at 5:35 PMHere's Why We're A Bit Worried About Checkmate Pharmaceuticals' (NASDAQ:CMPI) Cash Burn Situationnasdaq.com - January 7 at 8:39 AMCheckmate Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conferencefinance.yahoo.com - January 3 at 7:44 PMCheckmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Multi-Indication Trial Using Vidutolimodfinance.yahoo.com - December 20 at 9:28 AMCheckmate Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conferencefinance.yahoo.com - November 15 at 6:11 PMCheckmate Pharmaceuticals Presents Final Clinical Data for Phase 1b Study Evaluating Vidutolimod at The Society for Immunotherapy of Cancer (SITC) 36th Annual Meetingfinance.yahoo.com - November 12 at 11:47 AMCheckmate Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Updatefinance.yahoo.com - November 12 at 11:47 AMCheckmate Pharmaceuticals to Present at the Jefferies London Healthcare Conferencefinance.yahoo.com - November 11 at 5:47 PMCheckmate Pharmaceuticals Announces Final Data Presentation for Phase 1b Study Evaluating Vidutolimod at The Society for Immunotherapy of Cancer (SITC) 36th Annual Meetingfinance.yahoo.com - November 1 at 12:48 PMCheckmate Pharmaceuticals Announces CEO Transitionfinance.yahoo.com - October 27 at 5:22 PMCheckmate Pharmaceuticals Announces Webcast on Innate Immune Modulators and Vidutolimod (CMP-001)finance.yahoo.com - October 20 at 5:34 PMWe're Keeping An Eye On Checkmate Pharmaceuticals' (NASDAQ:CMPI) Cash Burn Ratefinance.yahoo.com - October 13 at 1:23 PMOne Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) insider upped their stake by 2.5% in the previous yearnasdaq.com - October 9 at 1:06 PMWhy BofA Turned Bullish On Checkmate Pharmaceuticals, But Slashed Price Targetmarkets.businessinsider.com - October 6 at 9:43 PMCheckmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conferencefinance.yahoo.com - September 14 at 9:12 PMCheckmate Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conferencefinance.yahoo.com - September 7 at 8:06 AMPeek Under The Hood: VTI Has 11% Upsidenasdaq.com - August 21 at 9:14 AMCheckmate Pharmaceuticals Inc.barrons.com - August 12 at 11:00 PMCheckmate Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Updatefinance.yahoo.com - August 12 at 5:59 PMCheckmate Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conferencefinance.yahoo.com - August 2 at 4:32 PM Get Checkmate Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. CMPI Media Mentions By Week CMPI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPI News Sentiment▼0.000.36▲Average Medical News Sentiment CMPI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPI Articles This Week▼00▲CMPI Articles Average Week Get Checkmate Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Poseida Therapeutics News Today Coherus BioSciences News Today INmune Bio News Today Fennec Pharmaceuticals News Today Sutro Biopharma News Today Agenus News Today Candel Therapeutics News Today Adverum Biotechnologies News Today Opthea News Today Metagenomi News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMPI) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkmate Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
